| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.1840160304 |
| P698 | PubMed publication ID | 1380479 |
| P50 | author | Dominique C Valla | Q41855926 |
| P2093 | author name string | Yamamoto AM | |
| Lunel F | |||
| Perrin M | |||
| Abuaf N | |||
| Huraux JM | |||
| Frangeul L | |||
| Borotto E | |||
| Grippon P | |||
| Le Coz Y | |||
| P2860 | cites work | Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 |
| An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis | Q27860909 | ||
| Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis | Q29547897 | ||
| Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. | Q33665767 | ||
| LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase | Q34205552 | ||
| Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. | Q34569386 | ||
| Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum | Q36349992 | ||
| Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily | Q36351347 | ||
| Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance | Q37405465 | ||
| Autoimmunity and liver disease | Q37949387 | ||
| Autoantibodies and antigens in liver diseases--updated | Q38712709 | ||
| Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum | Q39259192 | ||
| Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders | Q42984634 | ||
| Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. | Q42984818 | ||
| Second generation (RIBA) test in diagnosis of chronic hepatitis C | Q42985320 | ||
| Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity | Q42985404 | ||
| Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis | Q42987955 | ||
| Detection of hepatitis C viral sequences in non-A, non-B hepatitis. | Q43564387 | ||
| Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis | Q44086661 | ||
| Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis | Q44208719 | ||
| Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands | Q44491740 | ||
| Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? | Q45257325 | ||
| Antibody to superoxide dismutase, autoimmune hepatitis, and antibody tests for hepatitis C virus | Q45853586 | ||
| Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process | Q52847990 | ||
| Antibodies to liver/kidney microsome1 in chronic active hepatitis recognize specific forms of hepatic cytochrome P-450 | Q58483831 | ||
| Is autoimmune chronic active hepatitis a HCV-related disease? | Q58803543 | ||
| Unexplained hepatitis following halothane | Q67449270 | ||
| Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2 | Q67970209 | ||
| Type 2 autoimmune hepatitis and hepatitis C virus infection | Q68082887 | ||
| False-positive anti-HCV tests in rheumatoid arthritis | Q68088292 | ||
| Detection and further characterization of a newly described microsomal autoantibody associated with chronic delta infection | Q68957734 | ||
| A human cytochrome P-450 is recognized by anti-liver/kidney microsome antibodies in autoimmune chronic hepatitis | Q69056709 | ||
| Hepatic Disorders Associated with Liver/Kidney Microsomal Antibodies | Q69342776 | ||
| A classification of chronic hepatitis | Q70092609 | ||
| Natural history, clinical features, and treatment of autoimmune hepatitis | Q71310537 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 630-636 | |
| P577 | publication date | 1992-09-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Liver/kidney microsome antibody type 1 and hepatitis C virus infection | |
| P478 | volume | 16 |
| Q43038734 | A young woman with chronic hepatitis |
| Q77369430 | Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis |
| Q33433889 | Anti-Hepatitis C Virus Serology in Immune Thrombocytopenia: A Retrospective Analysis in 101 Patients |
| Q27473555 | Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA |
| Q45780655 | Anti-rat liver microsomal and cytosolic antibodies in hepatitis C virus infection |
| Q44934625 | Antibodies to P450IID6, SLA, PDH‐E2 and BCKD‐E2 in Japanese patients with chronic hepatitis |
| Q33914734 | Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis |
| Q24804699 | Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease |
| Q74529379 | Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview |
| Q34545376 | Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis |
| Q54939025 | Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease? |
| Q38889147 | Autoantibodies in Autoimmune Liver Diseases-Methods of Detection and Interpretation: An Update for the Reporting Pathologist |
| Q46699490 | Autoantibodies in autoimmune hepatitis: Anti-liver kidney microsome type 1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1) antibodies |
| Q37672213 | Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease |
| Q73978555 | Autoimmune Disease Is Not a Feature of Hepatitis C Infection in Ireland |
| Q36490242 | Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview |
| Q59349440 | Autoimmune hepatitis |
| Q34371115 | Autoimmune hepatitis and its variant syndromes |
| Q45762603 | Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. |
| Q36574524 | Autoimmune hepatitis--approach to diagnosis. |
| Q40590020 | Autoimmune hepatitis. Evolving concepts and treatment strategies |
| Q34936564 | Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features |
| Q40775169 | Autoimmune hepatitis: the lesson of the discovery of hepatitis C virus |
| Q38046450 | Autoimmune manifestations in viral hepatitis |
| Q35573912 | Autoimmune overlapping syndromes |
| Q34936701 | Autoimmunity and viruses |
| Q41115162 | Autoimmunity in hepatitis C and D virus infection |
| Q34005303 | Autoimmunity in liver diseases |
| Q45066635 | Biology of hepatitis C viruses: clinical implications |
| Q36699786 | Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection |
| Q41662981 | Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C |
| Q43038818 | Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera |
| Q67555835 | Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis |
| Q42986166 | Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis |
| Q34626547 | Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection |
| Q35960885 | Clinical manifestations of hepatitis C. |
| Q34473724 | Current Concepts in the Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis |
| Q41438951 | Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens |
| Q41199724 | Cytochromes P450 and UDP-glucuronosyl-transferases as hepatocellular autoantigens |
| Q36734483 | Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection |
| Q44385144 | Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children. |
| Q73483411 | Diversity of antinuclear antibody responses in hepatocellular carcinoma |
| Q71818738 | Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes |
| Q35594867 | Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics |
| Q91935600 | Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions |
| Q42537961 | Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis. |
| Q78849136 | Expression of endocrine autoantibodies in chronic hepatitis C, before and after interferon-alpha therapy |
| Q34112677 | Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas |
| Q71958731 | Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity |
| Q53359978 | Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. |
| Q70496840 | Genetic predispositions for the immunological features of chronic active hepatitis |
| Q43479532 | Hepatitis C virus and autoimmunity: Fortuitous association or reality? |
| Q27472999 | Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact? |
| Q40443039 | Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction |
| Q41225114 | Hepatitis C virus infection: clinical aspects and treatment with interferon alfa |
| Q36642065 | Hepatitis C: progress and problems |
| Q41428161 | Hepatotropic viruses and autoimmunity 1997. |
| Q34408786 | Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease |
| Q43609013 | High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy |
| Q45886279 | Histopathology of hepatitis C and haemophilia |
| Q53371048 | Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience |
| Q43036194 | In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C |
| Q42978301 | Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. |
| Q43041939 | Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. |
| Q34408327 | Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection |
| Q77932213 | Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease |
| Q42980063 | Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis |
| Q24799970 | Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, Greece |
| Q42981058 | Managing patients on interferon therapy |
| Q42983683 | Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. |
| Q45751401 | Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection |
| Q45777834 | Non-organ specific autoantibodies associated with chronic C virus hepatitis. |
| Q42980425 | Non-organ specific autoantibodies in children with chronic hepatitis C. |
| Q35131501 | Overlap syndromes of autoimmune hepatitis: what is known so far. |
| Q40442669 | Pathology of hepatitis C virus infection |
| Q82719034 | Performance parameters of the conventional serological markers for autoimmune hepatitis |
| Q27478411 | Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease |
| Q42991279 | Plasma hydroxy-metronidazole/metronidazole ratio in hepatitis C virus-induced liver disease |
| Q45786212 | Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia |
| Q44177422 | Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population |
| Q27477841 | Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort |
| Q82205757 | Prevalence of non-organ-specific autoantibodies in a rural community from northeastern Brazil: a population-based study |
| Q41667301 | Recent developments in autoimmune liver diseases |
| Q33496785 | Risks and benefits of interferon-alpha in the treatment of hepatitis |
| Q36119478 | Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases |
| Q41098844 | Sequence variability of hepatitis C virus and its clinical relevance |
| Q45784344 | Serum anti-liver cytosol antibodies type 1 in hepatitis C virus infection. |
| Q60364373 | Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C |
| Q41101401 | The epidemiology of hepatitis viruses B, C, and D. |
| Q35350742 | The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis |
| Q70496829 | Toward diagnostic criteria for autoimmune hepatitis |
| Q38496935 | Transitioning from Idiopathic to Explainable Autoimmune Hepatitis |
| Q33809587 | Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection |
| Q43754284 | Type II autoimmune hepatitis. What is the role of the hepatitis C virus? |
| Q27473554 | Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6 |
| Q40754969 | Viruses and auto-immune hepatitis |
Search more.